FdaApplication

NDA 021747

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBOEHRINGER INGELHEIM PHARMACEUTICALS INC
application_typeNDA
approval_date2011-10-07

Products (1)

ProductActive ingredientStrengthDosage form
COMBIVENT RESPIMATALBUTEROL SULFATE; IPRATROPIUM BROMIDEEQ 0.1MG BASE/INH;0.02MG/INHSPRAY, METERED;INHALATION

1 product